Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Tissue Sparing Therapy of Female Precancerous Genital Lesions With VITOM (VITOM)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2012 by Giuseppe Vercellino, Charite University, Berlin, Germany.
Recruitment status was:  Active, not recruiting
Information provided by (Responsible Party):
Giuseppe Vercellino, Charite University, Berlin, Germany Identifier:
First received: May 14, 2012
Last updated: May 16, 2012
Last verified: May 2012

Object of the study is the evaluation of the use of a rigid laparoscope for the diagnosis and therapy of lesions of the female genital tract as a substitution or a complementary method to colposcopy with the development of new standards for a tissue sparing therapy Use of existing laparoscopic instruments, which allow a better quality level in the diagnosis and therapy than the current routine.

Development of new optics and instruments, which allow a tissue sparing approach Pre and postoperative measurement of the cervical volume, to be sure that the tissue removal is kept to a minimum level Development of qualitaty parameters for the most tissue respecting operations of the uterine cervix Prospective evaluation of the influence of tissue sparing surgery on future pregnancies

Condition Intervention
Cervical Preinvasive Disease
Device: Vitom
Device: Colposcopy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Development of a Tissue Sparing Procedure for the Diagnosis and Therapy of Female Precancerous Genital Lesions Combining Endoscopic and Ultrasound Technics.

Further study details as provided by Giuseppe Vercellino, Charite University, Berlin, Germany:

Primary Outcome Measures:
  • Cervical volume removed [ Time Frame: İmmediately after surgery ]
    Cervical volume removed during the operation is recorded

  • İntraoperative Complications [ Time Frame: During the intraoperative ]
    Complications encountered during the prodecure

  • Short term complications [ Time Frame: Within 48 hours after operation ]
    Complications within 48 hours after operation

  • Late complications [ Time Frame: After 48 hours ]
    Complications occuring after 48 hours

Estimated Enrollment: 300
Study Start Date: April 2011
Estimated Study Completion Date: July 2012
Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Colposcopy
a Carl Zeiss colposcope with a magnification power from 4x to 20x, with green filter.
Device: Colposcopy

a Carl Zeiss colposcope with a magnification power from 4x to 20x, with green filter.

Patients treated by colposcopy

Experimental: Vitom
The VITOM system, consisting of the VITOM scope, xenon light source, HD camera system, AIDA HD documentation system, 1 monitor, and a mechanical support arm (all Karl Storz, Tuttlingen, Germany) is used for video exocolposcopy.
Device: Vitom
Patients treated and diagnosed by vitom


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Karnowsky-Index > 80,
  • 18-80 years,
  • CIN.

Exclusion Criteria:

  • Pregnancy,
  • Previous or current cancer,
  • Radio therapy of the pelvis,
  • Serious internistic accompanying diseases,
  • Psychiatric diseases,
  • HIV infection,
  • Drug addiction.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01601769

Charité University Hospital
Berlin, Germany, 12200
Sponsors and Collaborators
Charite University, Berlin, Germany
Study Director: Achim Schneider, MD, MPH Charité University Hospital Berlin, Germany
  More Information

Responsible Party: Giuseppe Vercellino, MD, Charite University, Berlin, Germany Identifier: NCT01601769     History of Changes
Other Study ID Numbers: ENDOCOLP
Study First Received: May 14, 2012
Last Updated: May 16, 2012

Keywords provided by Giuseppe Vercellino, Charite University, Berlin, Germany:
Cervical preinvasive disease
Leep processed this record on May 25, 2017